Interestingly, BRAF mutations and RAS mutations have been identified and generally considered mutually exclusive in thyroid cancer (72), but herein we found 3 patients harboring both of them, among which, 2 of 3 patients appeared to be RAIR-DTC. This evidence concerns the gene BRAF and thyroid cancer.